FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2516701064> ?p ?o ?g. }

• W2516701064 endingPage "67372" @default.
• W2516701064 startingPage "67360" @default.
• W2516701064 abstract "// Barbara Seliger 1 , Simon Jasinski-Bergner 1 , Dagmar Quandt 1 , Christine Stoehr 2 , Juergen Bukur 1 , Sven Wach 3 , Wolfgang Legal 3 , Helge Taubert 3 , Bernd Wullich 3 , Arndt Hartmann 2 1 Institute of Medical Immunology, Martin-Luther-University, Halle-Wittenberg, Germany 2 Institute of Pathology, Friedrich-Alexander-University, Erlangen-Nuremberg, Germany 3 Clinics for Urology, Friedrich-Alexander-University, Erlangen-Nuremberg, Germany Correspondence to: Barbara Seliger, email: Barbara.Seliger@uk-halle.de Keywords: HLA-E, non-classical HLA class I, renal cell carcinoma, tumor progression, immune escape Received: April 11, 2016     Accepted: July 27, 2016     Published: August 31, 2016 ABSTRACT The non-classical human leukocyte antigen E (HLA-E) expression is frequently overexpressed in tumor diseases, transplants and virus-infected cells and represents an immunomodulatory molecule by binding to the receptors CD94/NKG2A, -B and –C on NK and T cells. Due to its immune suppressive features HLA-E expression might represent an important mechanism of tumors to escape immune surveillance. While an aberrant expression of the non-classical HLA-G antigen in human renal cell carcinoma (RCC) has been demonstrated to be associated with a worse outcome of patients and reduced sensitivity to immune effector cell-mediated cytotoxicity, the expression and function of HLA-E has not yet been analyzed in this tumor entity. Higher levels of HLA-E transcripts were detected in all RCC cell lines and tumor lesions, which were tested in comparison to normal kidney epithelium. Immunohistochemical staining of a tissue microarray (TMA) using the HLA-E-specific monoclonal antibody TFL-033 recognizing the cytoplasmic HLA-E α-chain as monomer revealed a heterogeneous HLA-E expression in RCC lesions with the highest frequency in chromophobe RCC when compared to other RCC subtypes. HLA-E expression did not correlate with the frequency of CD3 + , CD4 + , CD8 + and FoxP3 + immune cell infiltrations, but showed an inverse correlation with infiltrating CD56 + cells. In contrast to HLA-G, HLA-E expression in RCCs was not statistically significant associated with a decreased disease specific survival. These data suggest that HLA-E overexpression frequently occurs in RCC and correlates with reduced immunogenicity." @default.
• W2516701064 created "2016-09-16" @default.
• W2516701064 creator A5001848404 @default.
• W2516701064 creator A5016256104 @default.
• W2516701064 creator A5018687596 @default.
• W2516701064 creator A5029462216 @default.
• W2516701064 creator A5044131715 @default.
• W2516701064 creator A5049585448 @default.
• W2516701064 creator A5051550342 @default.
• W2516701064 creator A5076712207 @default.
• W2516701064 creator A5080429438 @default.
• W2516701064 creator A5080939405 @default.
• W2516701064 date "2016-08-31" @default.
• W2516701064 modified "2023-10-12" @default.
• W2516701064 title "HLA-E expression and its clinical relevance in human renal cell carcinoma" @default.
• W2516701064 cites W1518364693 @default.
• W2516701064 cites W1529568247 @default.
• W2516701064 cites W1564749019 @default.
• W2516701064 cites W1665384871 @default.
• W2516701064 cites W1882502102 @default.
• W2516701064 cites W1901034394 @default.
• W2516701064 cites W1906987668 @default.
• W2516701064 cites W1908003672 @default.
• W2516701064 cites W1923868209 @default.
• W2516701064 cites W1979560263 @default.
• W2516701064 cites W1981158549 @default.
• W2516701064 cites W1981844137 @default.
• W2516701064 cites W1986935067 @default.
• W2516701064 cites W1992752083 @default.
• W2516701064 cites W1994126734 @default.
• W2516701064 cites W1999752919 @default.
• W2516701064 cites W2000520324 @default.
• W2516701064 cites W2002220805 @default.
• W2516701064 cites W2009728231 @default.
• W2516701064 cites W2014293022 @default.
• W2516701064 cites W2017824838 @default.
• W2516701064 cites W2022771415 @default.
• W2516701064 cites W2029268657 @default.
• W2516701064 cites W2038234029 @default.
• W2516701064 cites W2045585289 @default.
• W2516701064 cites W2046774198 @default.
• W2516701064 cites W2048181920 @default.
• W2516701064 cites W2050955309 @default.
• W2516701064 cites W2052439308 @default.
• W2516701064 cites W2068266393 @default.
• W2516701064 cites W2083233431 @default.
• W2516701064 cites W2084733717 @default.
• W2516701064 cites W2087810003 @default.
• W2516701064 cites W2088481746 @default.
• W2516701064 cites W2093591730 @default.
• W2516701064 cites W2105878567 @default.
• W2516701064 cites W2115767710 @default.
• W2516701064 cites W2116171543 @default.
• W2516701064 cites W2121073559 @default.
• W2516701064 cites W2121624081 @default.
• W2516701064 cites W2123149440 @default.
• W2516701064 cites W2126656019 @default.
• W2516701064 cites W2126665111 @default.
• W2516701064 cites W2129310196 @default.
• W2516701064 cites W2135138738 @default.
• W2516701064 cites W2144099498 @default.
• W2516701064 cites W2144891041 @default.
• W2516701064 cites W2150263602 @default.
• W2516701064 cites W2156563057 @default.
• W2516701064 cites W2161937716 @default.
• W2516701064 cites W2163667076 @default.
• W2516701064 cites W2169083371 @default.
• W2516701064 cites W2252529546 @default.
• W2516701064 cites W2275274887 @default.
• W2516701064 cites W2961880799 @default.
• W2516701064 doi "https://doi.org/10.18632/oncotarget.11744" @default.
• W2516701064 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5341881" @default.
• W2516701064 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27589686" @default.
• W2516701064 hasPublicationYear "2016" @default.
• W2516701064 type Work @default.
• W2516701064 sameAs 2516701064 @default.
• W2516701064 citedByCount "35" @default.
• W2516701064 countsByYear W25167010642017 @default.
• W2516701064 countsByYear W25167010642018 @default.
• W2516701064 countsByYear W25167010642019 @default.
• W2516701064 countsByYear W25167010642020 @default.
• W2516701064 countsByYear W25167010642021 @default.
• W2516701064 countsByYear W25167010642022 @default.
• W2516701064 countsByYear W25167010642023 @default.
• W2516701064 crossrefType "journal-article" @default.
• W2516701064 hasAuthorship W2516701064A5001848404 @default.
• W2516701064 hasAuthorship W2516701064A5016256104 @default.
• W2516701064 hasAuthorship W2516701064A5018687596 @default.
• W2516701064 hasAuthorship W2516701064A5029462216 @default.
• W2516701064 hasAuthorship W2516701064A5044131715 @default.
• W2516701064 hasAuthorship W2516701064A5049585448 @default.
• W2516701064 hasAuthorship W2516701064A5051550342 @default.
• W2516701064 hasAuthorship W2516701064A5076712207 @default.
• W2516701064 hasAuthorship W2516701064A5080429438 @default.
• W2516701064 hasAuthorship W2516701064A5080939405 @default.
• W2516701064 hasBestOaLocation W25167010641 @default.
• W2516701064 hasConcept C142724271 @default.
• W2516701064 hasConcept C147483822 @default.

• next